Author

A. J. Markmann

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Research Focus:host-pathogen & immune response· 2 Research Focus:drug response / drug discovery· 1 Organism:human· 1 Assay:proteomics· 1 Organism:virus· 1

Frequent Co-Authors

A. M. de Silva· 2 shared A. Grinyo· 1 shared B. D. McElvany· 1 shared B. J. Doranz· 1 shared B. Jiang· 1 shared D. R. Bhowmik· 1 shared E. Davidson· 1 shared F. Wang· 1 shared

Activity by Year

2020-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 25 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

A. M. de Silva

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

A semi-quantitative, rapid, point of care SARS-CoV-2 serologic assay predicts neutralizing antibody levels

A. J. Markmann, D. R. Bhowmik, B. Jiang, M. Van Hoy, F. Wang, Y. J. Hou, R. S. Baric, A. M. de Silva, L. A. Bartelt

This paper introduces a semi-quantitative lateral flow assay that correlates with neutralizing antibody levels in SARS-CoV-2 recovered individuals.

bioRxiv · May 30, 2023 · PreprintImmunology

A novel antigenic site spanning domains I and III of the Zika virus envelope glycoprotein is the target of strongly neutralizing human monoclonal antibodies

S. Graham, H. A. Tu, B. D. McElvany, N. R. Graham, A. Grinyo, E. Davidson, B. J. Doranz, S. A. Diehl, A. M. de Silva, A. J. Markmann

This study identifies a novel antigenic site on the Zika virus envelope glycoprotein targeted by a strongly neutralizing human monoclonal antibody, providing insights for vaccine design.

bioRxiv · Dec 21, 2020Immunology